Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes
Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Apr 18, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how to better predict health problems in childhood cancer survivors. Many survivors face ongoing health issues due to their previous treatments, and this study aims to use information provided by the patients themselves—like their symptoms, activity levels, sleep patterns, and heart rates—to identify those risks more accurately. By doing this, researchers hope to improve the care and outcomes for these survivors.
To participate in this study, you need to be at least 18 years old, have been diagnosed with childhood cancer at least five years ago, and currently not be receiving any cancer treatments. You also need to have access to a smartphone that can connect to the internet. Participants will regularly provide information about their health through surveys, which will help researchers understand the long-term effects of childhood cancer treatment. If you or someone you know fits these criteria, this study could be a great opportunity to contribute to better health monitoring for childhood cancer survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age at the time of study
- • Enrolled on SJLIFE
- • ≥5 years from initial diagnosis of pediatric cancer/malignancy
- • Currently not receiving cancer therapies
- • Access to web-enabled smartphone
- Exclusion Criteria:
- • Known severe neurocognitive impairment (e.g., estimated intelligence score \[FSIQ\] \<70), which requires proxies to complete daily symptom and PRO surveys;
- • \<3rd-grade reading level or not able to communicate in English;
- • Currently pregnant or reports planning to become pregnant in the next two years;
- • Lack of access to web-enabled smartphone, or not able to use/access internet from the device.
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier pediatric research institution dedicated to advancing the treatment and understanding of catastrophic diseases in children, particularly cancer and other life-threatening conditions. Renowned for its innovative clinical trials and cutting-edge research, St. Jude integrates patient care with scientific discovery to develop new therapies and improve outcomes for young patients. The hospital is committed to ensuring that no family receives a bill for treatment, travel, housing, or food, fostering a holistic approach to pediatric care. Through collaboration with global research networks, St. Jude aims to share its findings and expertise to enhance treatment options worldwide, making significant strides in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
I-Chang Huang, PhD
Principal Investigator
St. Jude Children's Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials